Ann Wright

1.7k total citations
23 papers, 1.3k citations indexed

About

Ann Wright is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Ann Wright has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Immunology. Recurrent topics in Ann Wright's work include Glycosylation and Glycoproteins Research (11 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Galectins and Cancer Biology (4 papers). Ann Wright is often cited by papers focused on Glycosylation and Glycoproteins Research (11 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Galectins and Cancer Biology (4 papers). Ann Wright collaborates with scholars based in United States, Canada and Switzerland. Ann Wright's co-authors include Sherie L. Morrison, Mi‐Hua Tao, Elvin A. Kabat, Carol Clayberger, Tamao Endo, R Warnke, L. Jeffrey Medeiros, Peter A. Vandenbergh, Yuji Sato and Kuo‐Hsuan Chang and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and The EMBO Journal.

In The Last Decade

Ann Wright

23 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann Wright United States 16 744 728 435 114 111 23 1.3k
Michael Hühn Germany 21 532 0.7× 391 0.5× 583 1.3× 194 1.7× 208 1.9× 38 1.2k
Ricarda Finnern Germany 20 1.1k 1.5× 1.1k 1.5× 466 1.1× 320 2.8× 364 3.3× 30 1.8k
Yashwant M. Deo United States 25 754 1.0× 1.0k 1.4× 893 2.1× 77 0.7× 492 4.4× 44 1.6k
Francisca A. Neethling United States 24 419 0.6× 199 0.3× 400 0.9× 34 0.3× 163 1.5× 42 2.4k
M S Co United States 15 419 0.6× 416 0.6× 218 0.5× 50 0.4× 145 1.3× 17 1.0k
Mahdi Habibi‐Anbouhi Iran 19 589 0.8× 452 0.6× 302 0.7× 71 0.6× 181 1.6× 68 975
S. V. S. Kashmiri United States 26 808 1.1× 765 1.1× 990 2.3× 125 1.1× 769 6.9× 60 2.1k
Bernard Y. Amegadzie United States 15 834 1.1× 144 0.2× 129 0.3× 55 0.5× 275 2.5× 18 1.3k
Carlota Wolfenstein‐Todel Argentina 23 996 1.3× 156 0.2× 964 2.2× 32 0.3× 183 1.6× 59 1.7k
Dodie Pouniotis Australia 21 707 1.0× 136 0.2× 764 1.8× 20 0.2× 198 1.8× 41 1.4k

Countries citing papers authored by Ann Wright

Since Specialization
Citations

This map shows the geographic impact of Ann Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Wright more than expected).

Fields of papers citing papers by Ann Wright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Wright. The network helps show where Ann Wright may publish in the future.

Co-authorship network of co-authors of Ann Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Wright. A scholar is included among the top collaborators of Ann Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Wright. Ann Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xuemei, et al.. (2018). A comparison of in vitro cytotoxicity assays in medical device regulatory studies. Regulatory Toxicology and Pharmacology. 97. 24–32. 90 indexed citations
2.
Liu, Xuemei, et al.. (2017). Development of a quantitative cytotoxicity assay using mouse lymphoma TK cells. Toxicology in Vitro. 45(Pt 1). 172–180. 1 indexed citations
3.
Wright, Ann, et al.. (2014). Development of a Curved, Stratified, In Vitro Model to Assess Ocular Biocompatibility. PLoS ONE. 9(5). e96448–e96448. 31 indexed citations
4.
Wright, Ann, et al.. (2014). Design and Development of an In Vitro Tear Replenishment System. Annals of Biomedical Engineering. 42(9). 1923–1931. 7 indexed citations
5.
Wright, Ann, et al.. (2005). COMPARATIVE CYTOTOXICITY POTENTIAL OF SOFT CONTACT LENS CARE PRODUCTS. Cutaneous and Ocular Toxicology. 24(1). 53–64. 18 indexed citations
6.
Wright, Ann, Yuji Sato, Tomoko Okada, et al.. (2000). In vivo trafficking and catabolism of IgG1 antibodies with Fc associated carbohydrates of differing structure. Glycobiology. 10(12). 1347–1355. 81 indexed citations
7.
8.
Wright, Ann & Sherie L. Morrison. (1997). Effect of glycosylation on antibody function: implications for genetic engineering. Trends in biotechnology. 15(1). 26–32. 221 indexed citations
9.
Endo, Tamao, Ann Wright, Sherie L. Morrison, & Akira Kobata. (1995). Glycosylation of the variable region of immunoglobulin G—site specific maturation of the sugar chains. Molecular Immunology. 32(13). 931–940. 41 indexed citations
10.
Wright, Ann & Sherie L. Morrison. (1994). Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1.. The Journal of Experimental Medicine. 180(3). 1087–1096. 151 indexed citations
11.
Wright, Ann, et al.. (1993). Antibody variable region glycosylation: biochemical and clinical effects. Springer Seminars in Immunopathology. 15(2-3). 259–73. 28 indexed citations
12.
Wright, Ann, et al.. (1993). Hybrid Antibodies. International Reviews of Immunology. 10(2-3). 177–186. 4 indexed citations
13.
Wright, Ann, et al.. (1992). Genetically‐Engineered Antibodies: Tools for the Study of Diverse Properties of the Antibody Molecule. Immunological Reviews. 130(1). 87–107. 7 indexed citations
14.
Wright, Ann, et al.. (1992). Genetically engineered antibodies: progress and prospects.. PubMed. 12(3-4). 125–68. 51 indexed citations
15.
Wright, Ann, Mi‐Hua Tao, Elvin A. Kabat, & Sherie L. Morrison. (1991). Antibody variable region glycosylation: position effects on antigen binding and carbohydrate structure.. The EMBO Journal. 10(10). 2717–2723. 120 indexed citations
16.
Wright, Ann, et al.. (1991). Production of genetically engineered antibodies in myeloma cells: Design, expression, and applications. Methods. 2(2). 125–135. 7 indexed citations
17.
Wright, Ann, Michael P. Link, SD Smith, et al.. (1989). Cytotoxic T lymphocytes specific for self tumor immunoglobulin express T cell receptor delta chain.. The Journal of Experimental Medicine. 169(5). 1557–1564. 84 indexed citations
18.
Clayberger, Carol, et al.. (1987). ABSENCE OF CELL SURFACE LFA-1 AS A MECHANISM OF ESCAPE FROM IMMUNOSURVEILLANCE. The Lancet. 330(8558). 533–536. 120 indexed citations
19.
Vandenbergh, Peter A., Ann Wright, & Anne K. Vidaver. (1985). Partial Purification and Characterization of a Polysaccharide Depolymerase Associated with Phage-Infected Erwinia amylovora. Applied and Environmental Microbiology. 49(4). 994–996. 12 indexed citations
20.
Vandenbergh, Peter A., Carlos F. Gonzalez, Ann Wright, & Blair S. Kunka. (1983). Iron-Chelating Compounds Produced by Soil Pseudomonads: Correlation with Fungal Growth Inhibition. Applied and Environmental Microbiology. 46(1). 128–132. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Hühn Breakdown of academic impact, for papers by Ricarda Finnern Breakdown of academic impact, for papers by Yashwant M. Deo Breakdown of academic impact, for papers by Francisca A. Neethling Breakdown of academic impact, for papers by M S Co Breakdown of academic impact, for papers by Mahdi Habibi‐Anbouhi Breakdown of academic impact, for papers by S. V. S. Kashmiri Breakdown of academic impact, for papers by Bernard Y. Amegadzie Breakdown of academic impact, for papers by Carlota Wolfenstein‐Todel Breakdown of academic impact, for papers by Dodie Pouniotis
Rankless by CCL
2026